Ladenburg Thalmann Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$2.16M Buy
10,283
+1,513
+17% +$317K 0.01% 836
2019
Q3
$1.48M Buy
8,770
+3,683
+72% +$623K 0.01% 979
2019
Q2
$932K Sell
5,087
-1,081
-18% -$198K 0.01% 1278
2019
Q1
$1.14M Sell
6,168
-2,626
-30% -$484K 0.01% 1099
2018
Q4
$1.47M Buy
8,794
+3,553
+68% +$595K 0.01% 821
2018
Q3
$1.01M Buy
5,241
+516
+11% +$99.5K 0.01% 1113
2018
Q2
$771K Hold
4,725
0.01% 1227
2018
Q1
$771K Buy
4,725
+247
+6% +$40.3K 0.01% 1227
2017
Q4
$671K Sell
4,478
-1,977
-31% -$296K 0.01% 1326
2017
Q3
$983K Buy
6,455
+1,876
+41% +$286K 0.01% 1007
2017
Q2
$590K Buy
4,579
+1,716
+60% +$221K 0.01% 1279
2017
Q1
$312K Buy
2,863
+405
+16% +$44.1K ﹤0.01% 1615
2016
Q4
$184K Sell
2,458
-89
-3% -$6.66K ﹤0.01% 1877
2016
Q3
$222K Sell
2,547
-35
-1% -$3.05K ﹤0.01% 1691
2016
Q2
$221K Sell
2,582
-18
-0.7% -$1.54K ﹤0.01% 1619
2016
Q1
$206K Sell
2,600
-1,684
-39% -$133K ﹤0.01% 1589
2015
Q4
$538K Buy
4,284
+1,527
+55% +$192K 0.01% 985
2015
Q3
$289K Buy
2,757
+694
+34% +$72.7K 0.01% 1241
2015
Q2
$257K Buy
2,063
+415
+25% +$51.7K ﹤0.01% 1427
2015
Q1
$195K Sell
1,648
-34
-2% -$4.02K ﹤0.01% 1593
2014
Q4
$196K Buy
1,682
+100
+6% +$11.7K ﹤0.01% 1437
2014
Q3
$173K Buy
1,582
+51
+3% +$5.58K ﹤0.01% 1290
2014
Q2
$140K Sell
1,531
-514
-25% -$47K ﹤0.01% 1400
2014
Q1
$147K Buy
2,045
+170
+9% +$12.2K ﹤0.01% 1296
2013
Q4
$140K Sell
1,875
-352
-16% -$26.3K ﹤0.01% 1261
2013
Q3
$163K Buy
2,227
+50
+2% +$3.66K 0.01% 1104
2013
Q2
$177K Buy
+2,177
New +$177K 0.01% 1035